Prevalence of symptomatic and silent stress-induced perfusion defects in diabetic patients with suspected coronary artery disease referred for myocardial perfusion scintigraphy

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 32, Issue 1, 2005, Pages 60-69

  Prior, John O ^a   Monbaron, David ^a   Koehli, Melanie ^a   Calcagni, Maria Lucia ^a   Ruiz, Juan ^a   Delaloye, Angelika Bischof ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Diabetes; Myocardial ischaemia; Myocardial perfusion scintigraphy; Silent myocardial ischaemia; Single photon emission computed tomography

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; THALLIUM 201;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ERECTILE DYSFUNCTION; EXERCISE TEST; FEMALE; HEART DISEASE; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PREDICTION; PREVALENCE; QUANTITATIVE ANALYSIS; SILENT MYOCARDIAL ISCHEMIA; ST SEGMENT DEPRESSION; SYMPTOMATOLOGY; THORAX PAIN;

ADULT; AGED; AGED, 80 AND OVER; CAUSALITY; COMORBIDITY; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS; EXERCISE TEST; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE; PROGNOSIS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SWITZERLAND; TECHNETIUM TC 99M SESTAMIBI;

EID: 12444325541     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1591-0     Document Type: Article

References (37)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998;21:1414-31.
2. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial. Diabetes Care 1993;16:434-44.
3. Klein J, Chao SY, Berman DS, Rozanski A. Is 'silent' myocardial ischemia really as severe as symptomatic ischemia? The analytical effect of patient selection biases. Circulation 1994;89:1958-66.
4. Fowler PB. The UK prospective diabetes study. Lancet 1998;352:1933; author reply 1934.
5. Passa P, Drouin P, Issa-Sayegh M, Blasco A, Masquet C, Monassier JP, Paillole C. Coronary disease and diabetes. Diabetes Metab 1995;21:446-51.
6. Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association. Diabetes Care 1998;21:1551-9.
7. Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint EJ, Harbinson M, et al. Myocardial perfusion scintigraphy: the evidence. A consensus conference organised by the British Cardiac Society, the British Nuclear Cardiology Society and the British Nuclear Medicine Society, endorsed by the Royal College of Physicians of London and the Royal College of Radiologists. Eur J Nucl Med Mol Imaging 2004; 31:261-91. DOI 10.1007/s00259-003-1344-5.
8. Kang X, Berman DS, Lewin HC, Cohen I, Friedman JD, Germano G, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus. Am Heart J 1999;138:1025-32.
9. Giri S, Shaw LJ, Murthy DR, Travin MI, Miller DD, Hachamovitch R, et al. Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease. Circulation 2002; 105:32-40.
10. Koistinen MJ. Prevalence of asymptomatic myocardial ischaemia in diabetic subjects. Br Med J 1990;301:92-5.
11. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group. Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Am J Cardiol 1997; 79:134-9. DOI 10.1016/S0002-9149(96)00699-6.
12. Weiner DA, Ryan TJ, Parsons L, Fisher LD, Chaitman BR, Sheffield LT, Tristani FE. Significance of silent myocardial ischemia during exercise testing in patients with diabetes mellitus: a report from the Coronary Artery Surgery Study (CASS) registry. Am J Cardiol 1991;68:729-34.
13. Wackers FJT, Young LH, Inzucchi SE, Chyun DA, Davey JA. Detection of ischemia in asymptomatic diabetics: preliminary results of the DIAD study. J Am Coll Cardiol 2003;41:409a.
14. Rose G, Blackburn H, Gillum RF, Prineas RJ. Cardiovascular survey methods. 2nd edn. Geneva: WHO; 1982.
15. Imaging guidelines for nuclear cardiology procedures, part 2. American Society of Nuclear Cardiology. J Nucl Cardiol 1999;6:G47-84.
16. Berman DS, Kiat H, Friedman JD, Wang FP, van Train K, Matzer L, et al. Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study. J Am Coll Cardiol 1993;22:1455-64.
17. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. Circulation 1998;97:535-43.
18. Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care 1999;22:1396-400.
19. Vanzetto G, Halimi S, Hammoud T, Fagret D, Benhamou PY, Cordonnier D, et al. Prediction of cardiovascular events in clinically selected high-risk NIDDM patients. Prognostic value of exercise stress test and thallium-201 single-photon emission computed tomography. Diabetes Care 1999;22:19-26.
20. Inoguchi T, Yamashita T, Umeda F, Mihara H, Nakagaki O, Takada K, et al. High incidence of silent myocardial ischemia in elderly patients with non insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 2000;47:37-44. DOI 10.1016/S0168-8227(99)00102-3.
21. De Lorenzo A, Lima RSL, Siqueira-Filho AG, Pantoja MR. Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. Am J Cardiol 2002;90:827-32. DOI 10.1016/S0002-9149(02)02702-9.
22. Wackers F, Young L, Inzucchi S, Chyun D, Davey J. The prevalence of silent myocardial ischemia in asymptomatic patients with type 2 diabetes meltitus: results of the DIAD study. Diabetes 2003;52:A56.
23. Wackers FTJ, Young LH, Chyun DA, Davey JA, Inzucchi SE. Predictors of silent myocardial ischemia in patients with type 2 diabetes mellitus: results from the DIAD study. Diabetologia 2003;46:A23-4.
24. McCulloch DK, Campbell IW, Wu FC, Prescott RJ, Clarke BF. The prevalence of diabetic impotence. Diabetologia 1980; 18:279-83.
25. Zaret B, Beller GA. Nuclear cardiology - state of the art and future directions. 2nd edn. St. Louis: Mosby; 1999.
26. Pancholy SB, Schalet B, Kuhlmeier V, Cave V, Heo J, Iskandrian AS. Prognostic significance of silent ischemia. J Nucl Cardiol 1994;1:434-40.
27. Valensi P, Sachs RN, Lormeau B, Taupin JM, Ouzan J, Blasco A, et al. Silent myocardial ischaemia and left ventricle hypertrophy in diabetic patients. Diabetes Metab 1997;23:409-16.
28. Cosson E, Guimfack M, Paries J, Paycha F, Attali JR, Valensi P. Are silent coronary stenoses predictable in diabetic patients and predictive of cardiovascular events? Diabetes Metab 2003;29:470-6.
29. Zeiher AM, Krause T, Schachinger V, Minners J, Moser E. Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 1995;91:2345-52.
30. Schindler TH, Nitzsche E, Magosaki N, Brink I, Mix M, Olschewski M, et al. Regional myocardial perfusion defects during exercise, as assessed by three dimensional integration of morphology and function, in relation to abnormal endothelium dependent vasoreactivity of the coronary microcirculation. Heart 2003;89:517-26.
31. Hasdai D, Gibbons RJ, Holmes Jr DR, Higano ST, Lerman A. Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 1997;96:3390-5.
32. Blumenthal RS, Becker DM, Yanek LR, Aversano TR, Moy TF, Kral BG, Becker LC. Detecting occult coronary disease in a high-risk asymptomatic population. Circulation 2003;107:702-7. DOI 10.1161/01.CIR.0000048127.93169.88.
33. Verna E, Ceriani L, Giovanella L, Binaghi G, Garancini S. "False-positive" myocardial perfusion scintigraphy findings in patients with angiographically normal coronary arteries: insights from intravascular sonography studies. J Nucl Med 2000;41:1935-40.
34. Nitenberg A, Ledoux S, Valensi P, Sachs R, Attali JR, Antony I. Impairment of coronary microvascular dilation in response to cold pressor-induced sympathetic stimulation in type 2 diabetic patients with abnormal stress thallium imaging. Diabetes 2001;50:1180-5.
35. Nitenberg A, Valensi P, Sachs R, Cosson E, Attali JR, Antony I. Prognostic value of epicardial coronary artery constriction to the cold pressor test in type 2 diabetic patients with angiographically normal coronary arteries and no other major coronary risk factors. Diabetes Care 2004;27:208-15.
36. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 2000; 101:1899-906.
37. Halcox JPJ, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002;106:653-8. DOI 10.1161/01.CIR.0000025404.78001.D8.